Affordable Access

High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.

Authors
Type
Published Article
Journal
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed
Publication Date
Volume
57
Issue
2
Pages
100–105
Identifiers
PMID: 8634923
Source
Medline
License
Unknown

Abstract

A proportion of refractory NHL patients will respond to high-dose ara-C + mitoxantrone, despite that severe myelosuppression is frequently encountered.

Statistics

Seen <100 times